| Prophylactic treatment with BX795 blocks activation of AKT and its downstream targets to protect vaginal keratinocytes and vaginal epithelium from HSV-2 infection K Madavaraju, T Yadavalli, SK Singh, F Qatanani, D Shukla Antiviral research 194, 105145, 2021 | 7 | 2021 |
| Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry RK Suryawanshi, CD Patil, R Koganti, SK Singh, JM Ames, D Shukla Pathogens 10 (7), 803, 2021 | 5 | 2021 |
| Tolerability, pharmacokinetics, and anti-herpetic activity of orally administered BX795 T Yadavalli, SK Singh, AA Date, D Shukla Biomedicine & Pharmacotherapy 165, 115056, 2023 | 3 | 2023 |
| Putative targeting by BX795 causes decrease in protein kinase C protein levels and inhibition of HSV1 infection RK Suryawanshi, CD Patil, D Wu, PK Panda, SK Singh, I Volety, R Ahuja, ... Antiviral Research 208, 105454, 2022 | 3 | 2022 |
| Oral Self-Nanoemulsifying System Containing Ionic Liquid of BX795 Is Effective against Genital HSV-2 Infection in Mice Y Sutar, SK Singh, S Dhoble, J Mali, J Adams, T Yadavalli, AA Date, ... ACS Infectious Diseases 10 (1), 93-106, 2023 | 1 | 2023 |
| HerpDock: A GUI-based gateway to HSV-1 molecular docking insights SK Singh, D Kapoor, D Shukla Computational and Structural Biotechnology Journal 23, 3692-3701, 2024 | | 2024 |
| Use of a multi-omic approach to drug discovery for the treatment of HSV-1 infection T Yadavalli, K Madavaraju, R Koganti, SK Singh, J Ames, R Suryawanshi, ... Investigative Ophthalmology & Visual Science 64 (8), 5185-5185, 2023 | | 2023 |
| Enhancement of antiviral drug efficacy through multimodal mechanism of Au nanoparticles decorated ZnO tetrapods RK Suryawanshi, CD Patil, L Koujah, PK Panda, SK Singh, A Agelidis, ... | | 2023 |
Tejabhiram YadavalliUniversity of Illinois at Chicago在 uic.edu 的电子邮件经过验证
